title: Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison".
authors.affiliation: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
authors.forename: Zhang
authors.initials: Z
authors.lastname: Lin
authors.affiliation: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: xiaoyizou@163.com.
authors.forename: Zou
authors.initials: Z
authors.lastname: Xiaoyi
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy*
chemical_list: D000927:Anticonvulsants; D011760:Pyrrolidinones; D000077287:Levetiracetam; C482793:brivaracetam; D010889:Piracetam
keywords: Brivaracetam; Efficacy; Indirect comparison; Levetiracetam; Meta-analysis